201 related articles for article (PubMed ID: 32797761)
21. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
[TBL] [Abstract][Full Text] [Related]
22. The cognitive safety of antimuscarinics in the treatment of overactive bladder.
Araklitis G; Robinson D
Expert Opin Drug Saf; 2020 Oct; 19(10):1303-1313. PubMed ID: 32857638
[TBL] [Abstract][Full Text] [Related]
23. Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):69-71. PubMed ID: 33497068
[TBL] [Abstract][Full Text] [Related]
24. Disentangling drug contributions: anticholinergic burden in older adults linked to individual medications: a cross-sectional population-based study.
Bhatkhande G; Choudhry NK; Mahesri M; Haff N; Lauffenburger JC
BMC Geriatr; 2024 Jan; 24(1):44. PubMed ID: 38200457
[TBL] [Abstract][Full Text] [Related]
25. Anticholinergics: theoretical and clinical overview.
Nishtala PS; Salahudeen MS; Hilmer SN
Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981
[TBL] [Abstract][Full Text] [Related]
26. The cognitive impact of anticholinergics: a clinical review.
Campbell N; Boustani M; Limbil T; Ott C; Fox C; Maidment I; Schubert CC; Munger S; Fick D; Miller D; Gulati R
Clin Interv Aging; 2009; 4():225-33. PubMed ID: 19554093
[TBL] [Abstract][Full Text] [Related]
27. Is Ongoing Anticholinergic Burden Associated With Greater Cognitive Decline and Dementia Severity in Mild to Moderate Alzheimer's Disease?
Dyer AH; Murphy C; Segurado R; Lawlor B; Kennelly SP;
J Gerontol A Biol Sci Med Sci; 2020 Apr; 75(5):987-994. PubMed ID: 31613323
[TBL] [Abstract][Full Text] [Related]
28. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
[TBL] [Abstract][Full Text] [Related]
29. Use of anticholinergic medications by older adults with dementia.
Roe CM; Anderson MJ; Spivack B
J Am Geriatr Soc; 2002 May; 50(5):836-42. PubMed ID: 12028169
[TBL] [Abstract][Full Text] [Related]
30. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia.
Kalisch Ellett LM; Pratt NL; Ramsay EN; Barratt JD; Roughead EE
J Am Geriatr Soc; 2014 Oct; 62(10):1916-22. PubMed ID: 25284144
[TBL] [Abstract][Full Text] [Related]
31. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
32. Centrally-acting anticholinergic drugs- associations with mortality, hospitalisation and cognitive decline following dementia diagnosis in people receiving antidepressant and antipsychotic drugs.
Bishara D; Perera G; Harwood D; Taylor D; Sauer J; Funnell N; Gee S; Stewart R; Mueller C
Aging Ment Health; 2022 Sep; 26(9):1747-1755. PubMed ID: 34308718
[TBL] [Abstract][Full Text] [Related]
33. A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults.
Lockery JE; Broder JC; Ryan J; Stewart AC; Woods RL; Chong TT; Cloud GC; Murray A; Rigby JD; Shah R; Storey E; Ward SA; Wolfe R; Reid CM; Collyer TA; Ernst ME;
J Gen Intern Med; 2021 Jun; 36(6):1629-1637. PubMed ID: 33754317
[TBL] [Abstract][Full Text] [Related]
34. Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis.
Dmochowski RR; Thai S; Iglay K; Enemchukwu E; Tee S; Varano S; Girman C; Radican L; Mudd PN; Poole C
Neurourol Urodyn; 2021 Jan; 40(1):28-37. PubMed ID: 33098213
[TBL] [Abstract][Full Text] [Related]
35. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
36. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
Res Social Adm Pharm; 2020 Mar; 16(3):329-335. PubMed ID: 31182419
[TBL] [Abstract][Full Text] [Related]
37. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
38. SUFU white paper on overactive bladder anticholinergic medications and dementia risk.
Zillioux J; Welk B; Suskind AM; Gormley EA; Goldman HB
Neurourol Urodyn; 2022 Nov; 41(8):1928-1933. PubMed ID: 36066046
[TBL] [Abstract][Full Text] [Related]
39. Potentially inappropriate anticholinergic medication use in older adults with dementia.
Kachru N; Carnahan RM; Johnson ML; Aparasu RR
J Am Pharm Assoc (2003); 2015; 55(6):603-612. PubMed ID: 26501745
[TBL] [Abstract][Full Text] [Related]
40. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.
Carrière I; Fourrier-Reglat A; Dartigues JF; Rouaud O; Pasquier F; Ritchie K; Ancelin ML
Arch Intern Med; 2009 Jul; 169(14):1317-24. PubMed ID: 19636034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
